{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:55:33Z","timestamp":1791849333678,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.resinv.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T23:08:45Z","timestamp":1450220925000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Recent advances in chronic pulmonary aspergillosis"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-824X","authenticated-orcid":false,"given":"Koichi","family":"Izumikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2015.10.003_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2015.10.003_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7883\/yoken.66.312","article-title":"A case series of chronic necrotizing pulmonary aspergillosis and a new proposal","volume":"66","author":"Tashiro","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jiac.2013.10.016","article-title":"Pathogenesis and clinical features of chronic pulmonary aspergillosis-is it possible to distinguish CNPA and CCPA clinically?","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2015.10.003_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis","volume":"32","author":"Kohno","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature","volume":"56","author":"Agarwal","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2015.10.003_bib7","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10156-012-0414-7","article-title":"Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study","volume":"18","author":"Yoshida","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-012-0322-x","article-title":"Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan","volume":"40","author":"Saito","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.resinv.2015.10.003_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10156-012-0391-x","article-title":"The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma","volume":"18","author":"Fujita","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-198203000-00005","article-title":"Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity","volume":"61","author":"Binder","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.resinv.2015.10.003_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1148\/radiology.140.2.7255704","article-title":"\u201cSemi-invasive\u201d pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung","volume":"140","author":"Gefter","year":"1981","journal-title":"Radiology"},{"issue":"Suppl. 2","key":"10.1016\/j.resinv.2015.10.003_bib14","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1469-0691.2001.tb00006.x","article-title":"Chronic forms of pulmonary aspergillosis","volume":"7","author":"Denning","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.resinv.2015.10.003_bib15","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1080\/13693780400025179","article-title":"The invasive and saprophytic syndromes due to Aspergillus spp.","volume":"43","author":"Hope","year":"2005","journal-title":"Med Mycol"},{"issue":"Suppl. 3","key":"10.1016\/j.resinv.2015.10.003_bib16","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.","volume":"37","author":"Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib18","series-title":"Aspergillosis","author":"Denning","year":"2008"},{"key":"10.1016\/j.resinv.2015.10.003_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/322791","article-title":"Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis","volume":"184","author":"Crosdale","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/CCLM.2007.033","article-title":"Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis","volume":"45","author":"Vaid","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.resinv.2015.10.003_bib21","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/j.ijid.2009.06.028","article-title":"Genetic variability of innate immunity impacts human susceptibility to fungal diseases","volume":"14","author":"Carvalho","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/526500","article-title":"Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis","volume":"197","author":"Carvalho","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib23","first-page":"190","article-title":"Significance of lower respiratory tract cultures yielding Aspergillus spp. growth in a hospital without transplant patients","volume":"23","author":"Lucena","year":"2010","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.resinv.2015.10.003_bib24","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","article-title":"Aspergillus flavus: human pathogen, allergen and mycotoxin producer","volume":"153","author":"Hedayati","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.resinv.2015.10.003_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13693780701624639","article-title":"An aspergilloma caused by Aspergillus flavus","volume":"46","author":"Pasqualotto","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib26","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1164\/rccm.201202-0263IM","article-title":"Chronic pulmonary aspergillosis due to Aspergillus niger","volume":"186","author":"Park","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2015.10.003_bib27","first-page":"581","article-title":"Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward","volume":"49","author":"Tashiro","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-resistant aspergillosis due to cryptic species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.resinv.2015.10.003_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/EC.4.3.625-632.2005","article-title":"Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus","volume":"4","author":"Balajee","year":"2005","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.resinv.2015.10.003_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/599345","article-title":"Invasive aspergillosis due to Neosartorya udagawae","volume":"49","author":"Vinh","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.01556-09","article-title":"Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus?","volume":"48","author":"Sugui","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2015.10.003_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-014-9775-z","article-title":"Antifungal susceptibility profile of cryptic species of Aspergillus","volume":"178","author":"Alastruey-Izquierdo","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.resinv.2015.10.003_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.resinv.2015.10.003_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2015.10.003_bib36","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","article-title":"Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases","volume":"14","author":"Nam","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1378\/chest.112.2.541","article-title":"Chronic necrotizing pulmonary aspergillosis: approach to management","volume":"112","author":"Saraceno","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2015.10.003_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/0377-4929.42507","article-title":"Pathology of pulmonary aspergillomas","volume":"51","author":"Shah","year":"2008","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.resinv.2015.10.003_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/myc.12152","article-title":"Chronic pulmonary aspergillosis","volume":"57","author":"Schweer","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2015.10.003_bib40","first-page":"837146","article-title":"Fatal hemoptysis due to chronic cavitary pulmonary aspergillosis complicated by nontuberculous mycobacterial tuberculosis","author":"Kokkonouzis","year":"2011","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib41","first-page":"56","article-title":"Fatal massive hemoptysis in a patient on low-dose oral prednisone: chronic necrotizing pulmonary aspergillosis","volume":"52","author":"Vahid","year":"2007","journal-title":"Respir Care"},{"key":"10.1016\/j.resinv.2015.10.003_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcm035","article-title":"Pulmonary aspergillosis: a clinical update","volume":"100","author":"Zmeili","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.resinv.2015.10.003_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1440-1843.2009.01548.x","article-title":"Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis","volume":"14","author":"Kitasato","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2015.10.003_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2012.682228","article-title":"Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis","volume":"50","author":"Izumikawa","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib45","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cid\/ciu725","article-title":"A breath fungal secondary metabolite signature to diagnose invasive aspergillosis","volume":"59","author":"Koo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib46","series-title":"Guidelines for Management of Deep-Seated Mycosis 2014","author":"Izumikawa","year":"2014"},{"key":"10.1016\/j.resinv.2015.10.003_bib47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.1988.tb03653.x","article-title":"The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987)","volume":"31","author":"De Beule","year":"1988","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2015.10.003_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: study in 49 patients","volume":"23","author":"Dupont","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.resinv.2015.10.003_bib49","first-page":"557","article-title":"Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group","volume":"72","author":"Tsubura","year":"1997","journal-title":"Kekkaku"},{"key":"10.1016\/j.resinv.2015.10.003_bib50","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"Jain","year":"2006","journal-title":"J Infect"},{"issue":"527","key":"10.1016\/j.resinv.2015.10.003_bib51","first-page":"e17","article-title":"Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis","volume":"119","author":"Sambatakou","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.resinv.2015.10.003_bib52","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2015.10.003_bib53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis","volume":"57","author":"Al-Shair","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000362674","article-title":"Chronic pulmonary aspergillosis: an update on diagnosis and treatment","volume":"88","author":"Godet","year":"2014","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2015.10.003_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and safety of posaconazole for chronic pulmonary aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.coph.2007.05.004","article-title":"Pharmacodynamic implications for use of antifungal agents","volume":"7","author":"Lewis","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.resinv.2015.10.003_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/QCO.0b013e3283184611","article-title":"Therapeutic drug monitoring for triazoles","volume":"21","author":"Hope","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"Izumikawa","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib59","first-page":"688","article-title":"Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study","volume":"49","author":"Kohno","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06758.x","article-title":"Management of chronic pulmonary aspergillosis","volume":"1272","author":"Izumikawa","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.resinv.2015.10.003_bib61","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0003-4975(99)01334-X","article-title":"Aspergilloma: a series of 89 surgical cases","volume":"69","author":"Regnard","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.resinv.2015.10.003_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.athoracsur.2004.05.050","article-title":"Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma","volume":"79","author":"Kim","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.resinv.2015.10.003_bib63","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejcts.2008.06.049","article-title":"Surgical outcome of pulmonary aspergilloma","volume":"34","author":"Brik","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.resinv.2015.10.003_bib64","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.resinv.2015.10.003_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","article-title":"Azole-resistance in Aspergillus: proposed nomenclature and breakpoints","volume":"12","author":"Verweij","year":"2009","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.resinv.2015.10.003_bib66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-0691.2009.02911.x","article-title":"Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis","volume":"16","author":"Howard","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2015.10.003_bib67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13693780902717018","article-title":"Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma","volume":"48","author":"Bellete","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2015.10.003_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"Suppl 6","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.resinv.2015.10.003_bib69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib70","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/myc.12047","article-title":"Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis","volume":"56","author":"Howard","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2015.10.003_bib71","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib72","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib73","unstructured":"Standards, N.C.f.C.L.: Reference method for broth dilution antifungal susceptibility testing of filamentaous fungi; approved standard, 2nd ed., Document M38-A2; 2002."},{"key":"10.1016\/j.resinv.2015.10.003_bib74","doi-asserted-by":"crossref","unstructured":"EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008; 14: 982\u20134.","DOI":"10.1111\/j.1469-0691.2008.02086.x"},{"key":"10.1016\/j.resinv.2015.10.003_bib75","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2015.10.003_bib76","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/EC.00041-08","article-title":"Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance","volume":"7","author":"Cowen","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.resinv.2015.10.003_bib77","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib78","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.resinv.2015.10.003_bib79","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resinv.2015.10.003_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","author":"Verweij","year":"2015","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.resinv.2015.10.003_bib81","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534515001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534515001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T10:58:37Z","timestamp":1567421917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534515001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2212534515001410"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2015.10.003","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in chronic pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Japanese Respiratory Society. Published by Elsevier Japan KK All rights reserved.","name":"copyright","label":"Copyright"}]}}